Levonorgestrel IUD reduces blood loss in heavy menstrual bleeding by more than 90%

SAN DIEGO — Liletta, a levonorgestrel-releasing intrauterine system, reduced blood loss in people with heavy menstrual bleeding by more than 90%, regardless of BMI and parity, according to phase 3 data presented here.
As Healio previously reported, Liletta is currently approved by the FDA to prevent pregnancy for up to 6 years.
“This study was a planned phase 3 trial to add treatment of heavy menstrual bleeding to the FDA-approved indications for Liletta,” Mitchell D. Creinin, MD, a professor in the department of OB/GYN at the University of California Davis Health System in

SAN DIEGO — Liletta, a levonorgestrel-releasing intrauterine system, reduced blood loss in people with heavy menstrual bleeding by more than 90%, regardless of BMI and parity, according to phase 3 data presented here.
As Healio previously reported, Liletta is currently approved by the FDA to prevent pregnancy for up to 6 years.
“This study was a planned phase 3 trial to add treatment of heavy menstrual bleeding to the FDA-approved indications for Liletta,” Mitchell D. Creinin, MD, a professor in the department of OB/GYN at the University of California Davis Health System in